Pages that link to "Q38205228"

The following pages link to Cell transfer therapy for cancer: past, present, and future (Q38205228):

Displaying 12 items.

• Cancer immunotherapy: the beginning of the end of cancer? (Q26752277) (← links)
• Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models (Q26797285) (← links)
• Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion (Q33816097) (← links)
• Prolonged overall survival in gastric cancer patients after adoptive immunotherapy (Q35152386) (← links)
• Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity (Q35163556) (← links)
• Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy (Q36830759) (← links)
• IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. (Q37645042) (← links)
• Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity (Q38559350) (← links)
• Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy (Q38767385) (← links)
• Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma (Q57161414) (← links)
• Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1/PD-L1 pathway in human tumor cells (Q58608527) (← links)
• Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells (Q90119555) (← links)